fda glp-1 warning news november 2025 Ozempic Lawsuits: Possible Compensation For Damages GLP-1 Drugs: 2025 Pulse Survey

A new weight loss drug currently in the pipeline is retatrutide

She also believes that its important to expand the criteria for obesity so that more people qualify for these drugs through the proper channels, but says its crucial that patients receive ongoing care from a medical professional who has been licensed by the American Board of Obesity Medicine

Human evidence - Phase 3 TRANSCEND-T2D-1 (Eli Lilly, March 19, 2026) 537 adults with type 2 diabetes, randomized 1:1:1:1 to retatrutide 4, 9, or 12 mg or placebo

Exendin 2029 alleviates inflammatory and neuropathic chronic pain behaviors Exendin 2029 was further assessed for its efficacy in alleviating inflammatory and neuropathic chronic pain behaviors

Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans